What's breaking now, across thousands of outlets.
(RTTNews) - Inhibrx Biosciences, Inc. (INBX), a clinical-stage biopharmaceutical, on Friday reported a wider third-quarter loss, reflecting higher general and administrative expenses.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
Key PointsChip stocks fell broadly today as the fallout from Jensen Huang's resignation continues.
For three years, Wall Street bought the artificial intelligence boom through one ticker . This week, it went shopping for substitutes. Nvidia Corp.
Ottawa Senators get ready to face the Pittsburgh Penguins with four forwards sidelined due to injuries.
Hotels, a booking app, rented cabins, and cruise ships: Here's how each of these four travel stocks makes money when families leave home for the holidays.
Streaming revenue keeps growing for Spotify and Universal Music Group. Whether artists and songwriters share in it is the defining question for 2027.
